CD19-directed T cell–engaging antibodies for the treatment of autoimmune disease
JEM "Found in Translation" with Jennifer Michaelson and Patrick Baeuerle
08.04.2024
Jennifer S. Michaelson and Patrick A. Baeuerle (2024 Apr 08) CD19-directed T cell–engaging antibodies for the treatment of autoimmune disease. J Exp Med 221(5): e20240499. https://doi.org/10.1084/jem.20240499
Jennifer S. Michaelson, Chief Scientific Officer at Cullinan Oncology, and Patrick A. Baeuerle, scientific advisor to Cullinan
Oncology and honorary professor in immunology at Ludwig Maximilians University Munich, discuss the use of CD19-specific
T cell–engaging antibody therapies (TCEs) as therapeutics for autoimmune diseases.
